Please use this identifier to cite or link to this item:
http://cmuir.cmu.ac.th/jspui/handle/6653943832/75699
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jutatip Kaewmalee | en_US |
dc.contributor.author | Atcharaporn Ontawong | en_US |
dc.contributor.author | Acharaporn Duangjai | en_US |
dc.contributor.author | Chittreeya Tansakul | en_US |
dc.contributor.author | Vatcharin Rukachaisirikul | en_US |
dc.contributor.author | Chatchai Muanprasat | en_US |
dc.contributor.author | Chutima Srimaroeng | en_US |
dc.date.accessioned | 2022-10-16T07:01:58Z | - |
dc.date.available | 2022-10-16T07:01:58Z | - |
dc.date.issued | 2021-04-01 | en_US |
dc.identifier.issn | 14248247 | en_US |
dc.identifier.other | 2-s2.0-85104935465 | en_US |
dc.identifier.other | 10.3390/ph14040375 | en_US |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85104935465&origin=inward | en_US |
dc.identifier.uri | http://cmuir.cmu.ac.th/jspui/handle/6653943832/75699 | - |
dc.description.abstract | Isolated α,β-dehydromonacolin S (C5) from soil-derived fungus Aspergillus sclerotiorum PSU-RSPG178 was recently shown to exhibit an inhibitory effect against 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR) activity in vitro. In this study, we investigated the effects of C5 on lipid-lowering, hepatic steatosis, and hepatic gluconeogenesis in vivo. The control rats received a daily dose of either vehicle or C5 at 10 mg/kg, while the high-fat diet-induced obese (HFD) rats were administered vehicle; 1, 3, or 10 mg/kg C5; or 10 mg/kg lovastatin (LO) for 6 weeks. C5 significantly improved dyslipidemia and diminished liver enzymes, HMGR activity, insulin resistance, and hepatic steatosis, comparable to LO without any hepatotoxicity and nephrotoxicity in HFD rats. A higher efficacy of C5 in lipid-lowering activity and anti-hepatic steatosis was associated with a significant decrease in genes involved in lipid metabolism including sterol regulatory element binding protein (SREBP) 1c, SREBP2, liver X receptor alpha (LXRα), and peroxisome proliferator-activated receptor (PPAR) gamma (PPARγ) together with an increase in the PPAR alpha (PPARα). Correspondingly, C5 was able to down-regulate the lipid transporters cluster of differentiation 36 (CD36) and Niemann-Pick C1 Like 1 (NPC1L1), increase the antioxidant superoxide dismutase gene expression, and decrease the proinflammatory cytokines, tumor necrosis factor alpha (TNFα) and interleukin 1 beta (IL-1β). Impairment of hepatic gluconeogenesis and insulin resistance in HFD rats was restored by C5 through down-regulation of the gluconeogenic genes phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase (G6Pase), and the activation of AMP-dependent kinase serine (AMPK) and serine/threonine protein kinase B (Akt). Collectively, this novel C5 may be a therapeutic option for treating dyslipidemia, hepatic steatosis, and reducing potential risk for diabetes mellitus. | en_US |
dc.subject | Biochemistry, Genetics and Molecular Biology | en_US |
dc.subject | Pharmacology, Toxicology and Pharmaceutics | en_US |
dc.title | High-efficacy α,β-dehydromonacolin s improves hepatic steatosis and suppresses gluconeogenesis pathway in high-fat diet-induced obese rats | en_US |
dc.type | Journal | en_US |
article.title.sourcetitle | Pharmaceuticals | en_US |
article.volume | 14 | en_US |
article.stream.affiliations | University of Phayao | en_US |
article.stream.affiliations | Faculty of Medicine Ramathibodi Hospital, Mahidol University | en_US |
article.stream.affiliations | Prince of Songkla University | en_US |
article.stream.affiliations | Chiang Mai University | en_US |
Appears in Collections: | CMUL: Journal Articles |
Files in This Item:
There are no files associated with this item.
Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.